By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Abeona Therapeutics 



Cleveland  Ohio    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Abeona Therapeutics Enrolls First Patient In Phase 2 For EB-101 Gene Therapy Clinical Trial For Epidermolysis Bullosa 9/26/2016 9:51:11 AM
Abeona Therapeutics Completes Enrollment Of Low-Dose Cohort For ABO-102 In Phase 1/2 Clinical Trial For MPS IIIA Patients 8/29/2016 10:27:39 AM
Abeona Therapeutics Doses First Patient In Phase 1/2 Trial With ABO-102 Gene Therapy For Patients With Sanfilippo Syndrome Type A (MPS IIIA) 5/18/2016 9:01:20 AM
Abeona Therapeutics To Present At Source Capital Group's 2016 Disruptive Growth & Healthcare Conference 2/9/2016 10:22:06 AM
Abeona Therapeutics To Present At The 18th Annual BIO CEO & Investor Conference 2/4/2016 11:09:18 AM
Abeona Therapeutics, Formerly Known As PlasmaTech Biopharmaceuticals To Ring The Nasdaq Stock Market Closing Bell 6/19/2015 10:50:07 AM
Abeona Therapeutics Raises Foundation-Led $3.6M To Develop Therapies For Children Suffering From Rare Sanfilippo Diseases 12/1/2014 6:59:47 AM
Abeona Therapeutics Closes $750,000 In Seed Round To Develop Therapies For Children Suffering From Rare Sanfilippo Diseases 12/16/2013 9:54:21 AM
//-->